Related Experiment Video
Updated: Mar 9, 2026
08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
16.3K
Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis
Mitsunori Kayano1, Sayuri Higaki2, Jun-Ichi Satoh3
1Research Center for Global Agromedicine, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan ; Medical Genome Center, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
Biomarker Research
|December 22, 2016
Summary
New bioinformatics methods can detect mild cognitive impairment (MCI) using plasma microRNA (miRNA) biomarkers. Specific miRNA pairs show high accuracy for early MCI detection, aiding dementia prevention strategies.
Area of Science:
- Biomarkers
- Bioinformatics
- Neuroscience
Background:
- Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia, including Alzheimer's disease.
- Early detection of MCI and dementia is critical for secondary prevention strategies.
- Blood-based biomarkers offer a promising avenue for early MCI detection.
Purpose of the Study:
- To investigate the utility of differential correlation analysis for identifying plasma microRNA (miRNA) biomarkers for MCI.
- To compare the effectiveness of single molecular analysis versus interaction-based analysis for MCI detection.
Main Methods:
- Plasma miRNA expression profiles were analyzed from 23 Japanese MCI patients and 30 age- and race-matched controls.
- Differential correlation analysis was employed to identify significant miRNA expression patterns associated with MCI.
- Pathway analysis was conducted on identified MCI markers to explore biological implications.
Main Results:
- Twenty pairs of miRNAs were identified as potential MCI markers.
- Two miRNA pairs (hsa-miR-191/hsa-miR-101 and hsa-miR-103/hsa-miR-222) achieved an area under the curve (AUC) of 0.962 for MCI detection.
- Additional miRNA pairs involving hsa-miR-191 and hsa-miR-125b demonstrated high AUC values (≥ 0.95).
Conclusions:
- Differential correlation analysis is a powerful bioinformatics tool for uncovering complex biological interactions in diseases.
- This method identified effective MCI biomarkers missed by traditional single molecule analysis.
- The identified miRNA signatures, particularly those involving hsa-miR-191 and hsa-miR-125b, may play a key role in MCI and dementia progression.
